News & Publications
Read our latest news.
News
Amplifica to Present Positive Clinical Outcomes for AMP-303 at the Society for Investigative Dermatology Annual Meeting
Poster Highlights First-in-Human Results for the Treatment of Androgenetic AlopeciaSan Diego, CA, May 7, 2025 – Amplifica Holdings Group Inc.
Amplifica’s AMP-303 Study Unveils New Hope for Hair Loss Treatments
First-in-Human Trial Demonstrates Promising Results for the Treatment of Androgenetic Alopecia San Diego, CA, September 30, 2024 - Amplifica
Amplifica Announces First-in-Human Study Initiated
Amplifica’s AMP-303 safety and tolerability study targeting hair loss SAN DIEGO, CA., June 28, 2023 - Amplifica Holdings Group,
Amplifica Expands Pipeline for Hair Loss
Exclusive Licensing Agreement Allows for Access to Promising Early-Stage ProteinSAN DIEGO, CA., January 26, 2023 - Amplifica Holdings Group, Inc.
Amplifica Completes $11.8 Million Series A Financing to Enable Clinical Development of Lead Products to Treat Androgenic Alopecia
SAN DIEGO, CA - Amplifica Holdings Group, Inc. (“Amplifica”), a privately-held, clinical-stage biopharmaceutical company announced it successfully closed an
